Health
CHIEF-HF: Heart Failure Symptoms Improved With Canagliflozin in Remote Trial – DocWire News
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly…
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly improve symptoms and quality of life in adults with heart failure, whether or not they also had type 2 diabetes. Findings from…
Continue Reading
